Uichi Ikeda
Overview
Explore the profile of Uichi Ikeda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
221
Citations
3440
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Itagaki T, Ueki Y, Sunohara D, Aoki M, Nomoto F, Takamatsu T, et al.
Angiology
. 2024 Jan;
:33197231226348.
PMID: 38174990
The prognostic value of bone mineral content (BMC) for the clinical outcomes of patients with coronary artery disease (CAD) remains unknown. The present study evaluated the association between BMC index...
2.
Komatsu T, Minamisawa M, Okada A, Motoki H, Kasai T, Kuwahara K, et al.
JMA J
. 2023 Nov;
6(4):489-498.
PMID: 37941691
Introduction: Sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor (ARNI), is superior to enalapril for chronic heart failure (CHF) with reduced ejection fraction (EF). However, its efficacy and safety in older Japanese patients...
3.
Sunohara D, Miura T, Nomoto F, Itagaki T, Komatsu T, Mochidome T, et al.
J Cardiol Cases
. 2023 Sep;
28(3):128-131.
PMID: 37671263
Learning Objective: The efficacy of endovascular therapy (EVT) using stents for the invasive treatment of celiac artery compression syndrome (CACS) resulting from the compression of the median arcuate ligament has...
4.
Itagaki T, Miura T, Karasawa S, Nomoto F, Takamatsu T, Sunohara D, et al.
J Cardiol Cases
. 2023 Apr;
27(4):172-175.
PMID: 37012922
Learning Objective: We report a case of eosinophilic granulomatosis with polyangiitis (EGPA) presenting with cardiac involvement alone as organ damage, subsequently diagnosed with eosinophilic myocarditis as confirmed by an endomyocardial...
5.
Itagaki T, Ebisawa S, Kato T, Miura T, Oyama Y, Hashizume N, et al.
Angiology
. 2023 Mar;
75(6):536-545.
PMID: 36882389
We assessed the prognostic ability of several inflammation-based scores and compared their long-term outcomes in patients with peripheral artery disease (PAD) following endovascular treatment (EVT). We included 278 patients with...
6.
Komatsu T, Miura T, Nomoto F, Itagaki T, Sunohara D, Mochidome T, et al.
J Cardiol Cases
. 2023 Feb;
27(2):76-79.
PMID: 36788957
Learning Objective: Superior vena cava syndrome (SVCS) due to malignancy is not rare. Recently, endovascular treatment for SVCS has achieved acceptable results. However, SVC stenting in SVCS as having primary...
7.
Itagaki T, Miura T, Kasai T, Ikeda U
BMJ Case Rep
. 2022 Aug;
15(8).
PMID: 35922086
Hyperthyroidism has been recognised as the cause of secondary pulmonary hypertension (PH). However, several studies have reported that most PH cases due to hyperthyroidism are asymptomatic and not severe. Here,...
8.
Miura T, Miyashita Y, Hozawa K, Doijiri T, Kato T, Hayakawa N, et al.
PLoS One
. 2022 Jul;
17(7):e0270992.
PMID: 35797395
Purpose: Drug-eluting stents (DESs) play an important role in endovascular therapy (EVT) for femoropopliteal (FP) lesions. Cilostazol improves patency after bare-metal nitinol stent (BNS) implantation for femoropopliteal lesions. This study...
9.
Yamazaki K, Miura T, Sunohara D, Komatsu T, Mochidome T, Kasai T, et al.
J Cardiol Cases
. 2022 May;
25(5):279-281.
PMID: 35582068
Since the advent of the pneumococcal vaccine, cases of infective endocarditis (IE) from have become rare. Pneumococcal endocarditis (PE) may be the initial presentation in Austrian syndrome, which is very...
10.
Kato T, Miura T, Yamamoto S, Miyashita Y, Hashizume N, Shoin K, et al.
Heart Vessels
. 2022 Apr;
37(9):1596-1603.
PMID: 35396952
Endovascular treatment (EVT) is the main treatment for peripheral artery disease (PAD). Despite advances in device development, the restenosis rate remains high in patients with femoropopliteal lesions (FP). This study...